Tonix Pharma (TNXP)
13.14
-0.23 (1.72%)
Upcoming Events
Latest Headlines
Form 4 Tonix Pharmaceuticals For: Aug 20 Filed by: BAGGER RICHARD H
August 24, 2026 8:00 AM - SEC Filing
Tonix Pharma CEO named interim chief medical officer
August 18, 2026 4:01 PM - StreetInsider
Form 8-K Tonix Pharmaceuticals For: Aug 18
August 18, 2026 4:00 PM - SEC Filing
Form SCHEDULE 13G/A Tonix Pharmaceuticals Filed by: Sirenia Capital Management LP
August 14, 2026 8:36 AM - SEC Filing
Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: AQR CAPITAL MANAGEMENT LLC
August 13, 2026 9:18 AM - SEC Filing
Tonix Pharma (TNXP) PT Raised to $27 at Raymond James
August 10, 2026 1:46 PM - StreetInsider
Form 10-Q Tonix Pharmaceuticals For: Jun 30
August 10, 2026 8:10 AM - SEC Filing
Form 8-K Tonix Pharmaceuticals For: Aug 10
August 10, 2026 7:16 AM - SEC Filing
Tonix Pharma (TNXP) Tops Q2 EPS by 27c
August 10, 2026 7:02 AM - StreetInsider
Tonix Pharmaceuticals Reports Second Quarter 2026 Financial Results and Operational Highlights
August 10, 2026 7:00 AM - Globe NewsWire
Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences
August 5, 2026 7:00 AM - Globe NewsWire
Form 8-K Tonix Pharmaceuticals For: Aug 03
August 3, 2026 7:05 AM - SEC Filing
Tonix gets FDA alignment on Lyme disease antibody study design
August 3, 2026 7:00 AM - StreetInsider
Tonix Pharmaceuticals Announces Positive Minutes from Type C FDA Meeting to Discuss Adaptive Phase 2 Field Study of TNX-4800, a Human, anti-OspA Monoclonal Antibody, to Prevent Lyme Disease in the U.S
August 3, 2026 7:00 AM - Globe NewsWire
Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026
July 27, 2026 7:00 AM - Globe NewsWire
Tonix Pharmaceuticals CMO to retire in August 2026
July 21, 2026 4:08 PM - StreetInsider
Form 8-K Tonix Pharmaceuticals For: Jul 20
July 21, 2026 4:06 PM - SEC Filing
Raymond James sees potential for beats across biopharma coverage
July 21, 2026 6:12 AM - StreetInsider
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
July 15, 2026 9:05 AM - StreetInsider
Tonix Pharmaceuticals Announces Publication in the Peer-Reviewed Journal of Virology Assessing Virulence of the 2022 Outbreak Strain of Mpox in New Animal Models
July 15, 2026 9:05 AM - Globe NewsWire
Form 8-K Tonix Pharmaceuticals For: Jul 13
July 13, 2026 7:06 AM - SEC Filing
Tonix secures Medicare payer deal for TONMYA, expanding coverage to 46%
July 13, 2026 7:01 AM - StreetInsider
Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®
July 13, 2026 7:00 AM - Globe NewsWire
Form 4 Tonix Pharmaceuticals For: Jun 30 Filed by: SAENGER BRADLEY
July 9, 2026 9:06 AM - SEC Filing
Form S-8 Tonix Pharmaceuticals
July 1, 2026 5:01 PM - SEC Filing
Tonix enrolls first patient in Phase 2 MDD study of TNX-102 SL
June 29, 2026 7:25 AM - StreetInsider
Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)
June 29, 2026 7:25 AM - Globe NewsWire
Form 8-K Tonix Pharmaceuticals For: Jun 29
June 29, 2026 7:06 AM - SEC Filing
Raymond James Starts Tonix Pharma (TNXP) at Strong Buy
June 24, 2026 4:24 PM - StreetInsider
Form SCHEDULE 13G Tonix Pharmaceuticals Filed by: MILLENNIUM MANAGEMENT LLC
June 15, 2026 5:44 PM - SEC Filing
Form 4 Tonix Pharmaceuticals For: Jun 12 Filed by: Taylor Carolyn E.
June 15, 2026 7:00 AM - SEC Filing
Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026
June 11, 2026 7:00 AM - Globe NewsWire
Form 4 Tonix Pharmaceuticals For: Jun 09 Filed by: LEDERMAN SETH
June 9, 2026 5:30 PM - SEC Filing
Form 4 Tonix Pharmaceuticals For: Jun 08 Filed by: Stillwell Richard Newcomb
June 9, 2026 5:30 PM - SEC Filing
Form 8-K Tonix Pharmaceuticals For: Jun 08
June 8, 2026 7:05 AM - SEC Filing
Tonix Pharmaceuticals expands TONMYA coverage to 52 million lives
June 8, 2026 7:01 AM - StreetInsider
Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives
June 8, 2026 7:00 AM - Globe NewsWire
Full Article List
